- Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS2004 | 3. lékařská fakulta
- Number of severe bleeding complications according to classification used: Is unified classification of bleeding complications really necessary?2015 | 3. lékařská fakulta, Fakulta tělesné výchovy a sportu, Lékařská fakulta v Plzni, 1. lékařská fakulta
- Restoration Libertines and the Clash of their Weltanschauungen: Reason, Faith, and Human Nature in Buckingham's and Rochester's Writings2020 | Filozofická fakulta
- The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale2009 | 3. lékařská fakulta
- Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial2019 | Publikace bez příslušnosti k fakultě
- Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy2013 | 3. lékařská fakulta
- Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention2017 | Publikace bez příslušnosti k fakultě
- Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial2013 | 3. lékařská fakulta
- Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIXPublikace bez příslušnosti k fakultě
